Story type: Industry

  • World-leading National Centre for Inflammation Research to be established in Victoria following budget boost

    Hudson Institute of Medical Research today welcomed the Victorian Government’s initial investment to kick-start a National Centre for Inflammation Research (NCIR) to be established at the Monash Health Translation Precinct (MHTP) in Melbourne’s growing south-eastern corridor.…  Read more

    Professor Elizabeth Hartland, Director and CEO of Hudson Institute of Medical Research and Professor Paul Hertzog Associate Director of Hudson Institute of Medical Research in the TRF building, Clayton.
  • Medical research to benefit from Morningside Ventures appointment

    Australia’s medical research sector will benefit from the appointment of Hudson Institute inflammation scientist Associate Professor Ashley Mansell to global firm Morningside BioPharma Advisory,…  Read more

    Associate Professor Ashley Mansell, Hudson Institute, Morningside BioPharma Advisory
  • Future leaders selected for industry mentoring

    Ten Hudson Institute PhD students have been selected for the first time to participate in the high-level mentoring program, Industry Mentoring Network in STEM (IMNIS).…  Read more

    Ten PhD students selected for the first time to participate in the high-level mentoring program, IMNIS
  • Training to meet demand in the growing cell therapy industry

    There is a major gap in the rapidly growing cell therapy industry: qualified staff who can undertake the cell manufacturing needed as part of the therapy. …  Read more

    Associate Professor Rebecca Lim from the Amnion Cell Biology Research Group at Hudson Institute
  • Melbourne Inflammation Symposium

    More than 120 medical research scientists in the field of inflammation converged at Hudson Institute of Medical Research today to share knowledge and find solutions for patients across a broad range of diseases.…  Read more

    Husdson Institute CiiiD team
  • Preparing healthcare providers for possible cord-clamp change

    Our researchers are educating maternity and healthcare professionals for a possible change in birth practices by 2020, as their research moves from the laboratory to the clinic.…  Read more

  • Preserving reproductive health

    Although raising a family is an almost universal dream for couples, the reality is that infertility is increasing and will affect one in five Australian men and women, disrupting many aspirations.…  Read more

  • Childhood Cancer Research Symposium: Cutting-edge science advancing childhood cancer treatment

    More than 150 leading clinicians and scientists heard from national and international experts in childhood cancer at Hudson Institute of Medical Research on Wednesday, 13 February at a highly anticipated international symposium. The symposium was made possible through the generous support of our premium partner, the Children’s Cancer Foundation, along with the Isabella and Marcus…  Read more

  • Next Big Idea Award winners announced

    Researchers and students have pitched their innovative ‘Big Ideas’ tackling health conditions ranging from tackling Legionnaires disease to improving exercise science to a panel of research and commercialisation experts. It was all part of the Next Big Idea Award  on August 30, which aims to encourage, reward and facilitate commercially focused innovation among our PhD…  Read more

  • Turbo-charging chemotherapy for lung cancer

    A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers. And the hormone – known as follistatin – also appears to prevent kidney damage, a serious side effect of chemotherapy. The promising new ‘two birds, one stone’ treatment approach, which was…  Read more